Ostrum Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Ostrum Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.28M	Sell	54,098 -204	-0.4%	-$11.9K	0.18%	81
2025 Q4	$2.93M	Sell	54,302 -12,934	-19%	-$622K	0.14%	116
2025 Q3	$3.03M	Buy	67,236 +19,094	+40%	+$892K	0.14%	138
2025 Q2	$2.23M	Sell	48,142 -5,818	-11%	-$286K	0.1%	184
2025 Q1	$3.29M	Sell	53,960 -11,878	-18%	-$692K	0.17%	108
2024 Q4	$3.72M	Sell	65,838 -59,655	-48%	-$3.33M	0.32%	70
2024 Q3	$6.49M	Buy	125,493 +20,131	+19%	+$944K	0.54%	29
2024 Q2	$4.38M	Sell	105,362 -1,793	-2%	-$80.2K	0.38%	54
2024 Q1	$5.81M	Buy	107,155 +790	+0.7%	+$40.2K	0.46%	37
2023 Q4	$5.46M	Buy	106,365 +6,122	+6%	+$321K	0.47%	39
2023 Q3	$5.82M	Sell	100,243 -6,389	-6%	-$391K	0.54%	25
2023 Q2	$6.82M	Sell	106,632 -938	-0.9%	-$62.9K	0.57%	23
2023 Q1	$7.46M	Buy	+107,570	New	+$7.59M	0.65%	15

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ostrum Asset Management's BMY Position: Q1 2026 in Review

Ostrum Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.38% in Q1 2026, selling an estimated $11.9K and leaving 54,098 shares worth $3.28M. The position accounts for 0.18% of the portfolio, ranked #81.

Ostrum Asset Management first reported a position in BMY in Q1 2023 and has held it in 13 quarters since. The position peaked at $7.46M in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Ostrum Asset Management held 54,098 shares of Bristol-Myers Squibb worth $3.28M as of Q1 2026.
Ostrum Asset Management sold 204 Bristol-Myers Squibb shares in Q1 2026, an estimated $11.9K.
Bristol-Myers Squibb made up 0.18% of Ostrum Asset Management's portfolio in Q1 2026, its #81 holding.
Ostrum Asset Management first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 13 quarters since.
Ostrum Asset Management's Bristol-Myers Squibb position peaked at $7.46M in Q1 2023.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.